With this approach, known oncogenes recurrently involved in the onset and progression of CRC are confirmed, and a new candidate oncogene, whose role has been a matter of recent debate, CYP2C8, is proposed as an active driver of cancer. This evidence concerns the gene CYP2C8 and cancer.